AKT1 and central nervous system cancer: Treatment with eckol was also noted to induce a marked suppression of the PI3K and Akt activities, and completely inhibit Ras-Raf-1 interaction and Raf-1 and Erk activations in the sphere-forming glioma stem-like cells.